Junko Fujisaki

27PUBLICATIONS
72CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jun 02, 2026
New Compass for Precision Oncology: Evidence, Challenges, and Prospects of Circulating Tumor DNA in Colorectal Cancer.

|May 27, 2026
High-dose dexamethasone and prolonged infusion time prevent oxaliplatin-related hypersensitivity reactions in patients with metastatic colorectal cancer.

|May 04, 2026
A New Era of Salvage-Line Treatment for Metastatic Colorectal Cancer: The Role and Clinical Significance of Circulating Tumor DNA.

|Mar 15, 2026
Copy Number-Based Oncogene Dominance May Suggest ERBB2 Dependence and Trastuzumab Response in HER2-Positive Gastric Cancer.

Takeru Wakatsuki, Noriko Yamamoto, Naoki Ishizuka

|Dec 27, 2025
Ribosome biogenesis as a potential therapeutic target in KRAS mutant colorectal cancer.

Yui Tanaka, Mizuho Sakahara, Hitomi Yamanaka

|Dec 14, 2025
Glucocorticoids rarely required in granulocyte colony-stimulating factor-associated large-vessel vasculitis: Japanese cancer centre cohort.

Yuka Morita, Koichi Takeda, Hiroki Osumi

Pageof 5

Frequent Collaborators

9 joint publications

Eiji Shinozaki

8 joint publications

Kensei Yamaguchi

7 joint publications

Takeru Wakatsuki

7 joint publications

Akira Ooki